- Investing Ideas
- Global Biotech Stocks
Global Biotech Stocks
Results
1381
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1381 companies
Eli Lilly
Market Cap: US$837.2b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$935.58
7D
6.5%
1Y
26.7%
Johnson & Johnson
Market Cap: US$585.4b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$243.04
7D
1.1%
1Y
58.6%
AbbVie
Market Cap: US$369.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$208.84
7D
-0.3%
1Y
11.7%
Roche Holding
Market Cap: CHF 254.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 318.00
7D
1.8%
1Y
21.5%
AstraZeneca
Market Cap: UK£237.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£153.16
7D
7.1%
1Y
41.7%
Merck
Market Cap: US$298.8b
Operates as a healthcare company worldwide.
MRK
US$120.87
7D
1.0%
1Y
48.4%
Novartis
Market Cap: CHF 235.1b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 123.20
7D
3.4%
1Y
33.9%
Amgen
Market Cap: US$187.6b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$347.94
7D
-0.2%
1Y
18.2%
Thermo Fisher Scientific
Market Cap: US$182.6b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$491.46
7D
3.8%
1Y
12.2%
Gilead Sciences
Market Cap: US$173.4b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$139.71
7D
4.1%
1Y
30.3%
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 236.90
7D
3.7%
1Y
-45.2%
Pfizer
Market Cap: US$161.1b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$28.32
7D
4.7%
1Y
23.3%
Danaher
Market Cap: US$135.3b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$191.12
7D
5.3%
1Y
5.1%
Bristol-Myers Squibb
Market Cap: US$121.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$59.60
7D
1.8%
1Y
7.8%
Sanofi
Market Cap: €99.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€82.58
7D
0.7%
1Y
-14.0%
GSK
Market Cap: UK£85.7b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£21.44
7D
4.6%
1Y
51.3%
Vertex Pharmaceuticals
Market Cap: US$111.4b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
US$438.71
7D
1.3%
1Y
-7.6%
Chugai Pharmaceutical
Market Cap: JP¥14.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,779.00
7D
2.8%
1Y
31.9%
Regeneron Pharmaceuticals
Market Cap: US$78.2b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$761.85
7D
3.3%
1Y
32.9%
UCB
Market Cap: €50.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€264.50
7D
5.0%
1Y
75.6%
Takeda Pharmaceutical
Market Cap: JP¥9.2t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,802.00
7D
-0.7%
1Y
29.6%
Merck KGaA
Market Cap: €47.7b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€109.80
7D
4.5%
1Y
-6.8%
Zoetis
Market Cap: US$49.8b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS
US$117.94
7D
4.0%
1Y
-22.3%
Samsung BiologicsLtd
Market Cap: ₩71.9t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,554,000.00
7D
-3.2%
1Y
-5.5%
argenx
Market Cap: €40.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€647.20
7D
6.6%
1Y
24.4%
CSL
Market Cap: AU$66.7b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$138.93
7D
-3.0%
1Y
-45.2%
Galderma Group
Market Cap: CHF 36.7b
Operates as a dermatology company worldwide.
GALD
CHF 156.50
7D
4.6%
1Y
91.7%
Bayer
Market Cap: €39.0b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€39.70
7D
3.8%
1Y
97.5%
Lonza Group
Market Cap: CHF 35.8b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 512.20
7D
4.1%
1Y
0.2%
WuXi AppTec
Market Cap: CN¥303.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥99.99
7D
3.1%
1Y
57.4%
Haleon
Market Cap: UK£33.3b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.73
7D
1.6%
1Y
-2.8%
Alnylam Pharmaceuticals
Market Cap: US$42.3b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$318.85
7D
0.5%
1Y
35.3%
Otsuka Holdings
Market Cap: JP¥5.9t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,220.00
7D
-1.6%
1Y
47.6%
Insmed
Market Cap: US$35.1b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$162.43
7D
11.8%
1Y
134.8%
Teva Pharmaceutical Industries
Market Cap: US$35.0b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$30.08
7D
4.7%
1Y
118.0%
Sandoz Group
Market Cap: CHF 27.7b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 64.00
7D
5.8%
1Y
93.9%